The AERC Board of Directors met by phone conference November 10. The membership report shows significant increases over last year in the 8-10% range with about a 12% increase in rider fees.
The board heard reports on USEF and FEI from Jan Stevens (AERC liaison to USEF), Dr. Meg Sleeper (chair of the AERC-I Cmte.) and Valerie Kanavy (athlete representative to the FEI Technical Committee). Board members asked questions and the ladies were very helpful.
The Board also reviewed the Strategic Plan.
The Board passed a motion from the Trails and Land Management Committee to fund a Trails Grant project in Wisconsin.
The Board passed a motion to include Phenibut in the prohibited substance and referred back to committee the addition of Levothyroxine a drug used to treat hypothyroidism in horses. If you have a competing horse that is treated with Levothyroxine, the Board would like to hear from you.
Posted by AERC President, Michael Campbell
No comments:
Post a Comment